Axiom Investors LLC Exact Sciences Corp Transaction History

Axiom Investors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$77.66 - $99.74 $19.7 Million - $25.3 Million	-253,780 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$90.37 - $122.49 $4.36 Million - $5.91 Million	48,284 Added 23.5%	253,780 $22.9 Million
Q2 2019 Aug 07, 2019	BUY	$89.51 - $118.04 $5.75 Million - $7.58 Million	64,248 Added 45.49%	205,496 $24.3 Million
Q1 2019 May 13, 2019	SELL	$61.98 - $96.5 $6.54 Million - $10.2 Million	-105,552 Reduced 42.77%	141,248 $12.2 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $1.09 Million - $1.61 Million	-19,460 Reduced 7.31%	246,800 $15.6 Million
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $8.53 Million - $14.2 Million	176,540 Added 196.77%	266,260 $21 Million
Q2 2018 Aug 13, 2018	BUY	$37.84 - $69.96 $1.98 Million - $3.67 Million	52,410 Added 140.47%	89,720 $5.36 Million
Q1 2018 May 14, 2018	SELL	$39.82 - $57.53 $1.3 Million - $1.88 Million	-32,693 Reduced 46.7%	37,310 $1.51 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $1.73 Million - $2.25 Million	-37,191 Reduced 34.7%	70,003 $3.68 Million
Q3 2017 Nov 09, 2017	BUY	$37.05 - $47.12 $3.97 Million - $5.05 Million	107,194	107,194 $5.05 Million

671

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.